Pacira | PCRX - La Marge Brute Sur Les Ventes





La Marge Brute Sur Les Ventes Changement Date
Astellas Pharma JPY 444.26B 12.55B 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Cara Therapeutics USD 2.57M 1.11M 2025-03
Coherus Biosciences USD 8.7M 853K 2025-12
Heron Therapeutics USD 29.47M 3.17M 2025-12
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
J&J USD 17.24B 642M 2026-03
Ligand Pharmaceuticals USD 48.45M 8.22M 2026-03
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Novo Nordisk DKK 64.01B 1.19B 2025-06
Omeros USD -33.16M 18.52M 2024-06
Pacira USD 126.64M 15.61M 2026-03
Perrigo USD 325.5M 36.7M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
Supernus Pharmaceuticals USD 129.36M 34.68M 2026-03
Teva Pharmaceutical Industries USD 2.11B 547M 2026-03
Xeris Pharmaceuticals USD 72.15M 8.77M 2025-12
Xoma 992K 846K 2024-06
Zoetis USD 1.62B 20M 2026-03